Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Solventum

Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity

Check out these three stocks that are up more than 20% in 2025 and just increased their buyback capacity. One stock experiencing strong growth stands out.

MarketBeat

Solventum Stock: Analyst Estimates & Ratings

Solventum has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

What to Expect From Solventum's Next Quarterly Earnings Report

Solventum will release its third-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Do Wall Street Analysts Like Solventum Stock?

Although Solventum has outperformed the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

What to Expect From Solventum's Q2 2025 Earnings Report

Solventum will release its second-quarter earnings next month, and analysts anticipate a single-digit profit dip.

Barchart

How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks?

Solventum has outperformed relative to its healthcare equipment peers over the past year, but Wall Street analysts maintain a skeptical view on the stock’s outlook.

Barchart

Solventum Stock Outlook: Is Wall Street Bullish or Bearish?

Solventum has outperformed the broader market over the past year, yet analysts remain cautious about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Here's What to Expect From Solventum’s Next Earnings Report

Solventum is expected to unveil its first quarter results in the upcoming month, and analysts predict its bottom line to suffer in double digits.

Barchart

Solventum Stock: Is SOLV Outperforming the Healthcare Sector?

Despite outpacing the healthcare sector over the past year, analysts remain cautious about the stock’s prospects.

Barchart

Are Wall Street Analysts Predicting Solventum Stock Will Climb or Sink?

Although Solventum has outperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's growth potential.

Barchart

Earnings Preview: What to Expect from Solventum’s Report

Recently spun-off healthcare major Solventum is expected to announce its fourth-quarter results in the upcoming month and analysts predict an EPS of $1.31.

Barchart

Is Solventum Stock Underperforming the Dow?

Solventum has underperformed compared to the Dow index over the past three months, though analysts remain cautious about the stock’s growth prospects.

Barchart

A Peek at Cooper Companies's Future Earnings

Cooper Companies (NYSE:COO) is gearing up to announce its quarterly earnings on Thursday, 2024-12-05. Here's a quick overview of what investors should know before the release.

Benzinga

5 Analysts Have This To Say About Solventum

In the preceding three months, 5 analysts have released ratings for Solventum (NYSE:SOLV), presenting a wide array of perspectives from bullish to bearish.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is Wall Street Bullish or Bearish on Solventum Stock?

Due to Solventum’s underperformance relative to the broader S&P 500 Index over the past six months, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Solventum's Quarterly Earnings Preview: What You Need to Know

Solventum is scheduled to report its third-quarter results next month.

Barchart

Is Solventum Stock Outperforming the Nasdaq?

Solventum outperformed the broader market recently, but Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Solventum Stock?

Solventum has underperformed the broader market over the past three months, and Wall Street analysts are cautious about the stock's potential.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Solventum’s Q2 2024 Earnings: What to Expect

Solventum is gearing up to unveil its second-quarter earnings next month. Here’s what analysts are predicting.

Barchart

What to Expect From 3M’s Q2 2024 Earnings Report

3M is expected to release its second-quarter earnings later this month, and analysts project a double-digit profit dip.

Barchart

3 Dividend Kings That Cut (Or Will Cut) Their Dividends

Dividend aristocracy isn't always a sure thing. Here are 3 companies that have been or will be booted from the coveted king's list.

Barchart

After Its Historic Dividend Cut, Is 3M Stock Still Worth Buying?

3M stock is a Dividend King no more, as the company slashed its payout following the Solventum spinoff. Is the stock still a buy for investors seeking passive income?

Kiplinger

3M Stock Is Higher Despite Its Dividend Cut. Here's Why

3M is snapping its decades-long streak of dividend hikes, yet it's been one of the best Dow Jones stocks this week. Here's what you need to know.

International Business Times

Swan Song For General Electric As It Completes Demerger

The US conglomerate General Electric, co-founded more than 130 years ago by Thomas Edison, is opening a new chapter in its history on Tuesday: its break-up into three independent entities which will then concentrate on their disparate core businesses.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Walgreens Boots Alliance

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.